Ray G. Crispen
- Surgery top 10%
- Epidemiology
- Infectious Diseases top 10%
- Immunology
- Urology top 5%
- Co-authors
- Donald L. LammTimothy J. HolzerKenrad E. NelsonB. R. AndersenP. Jan GeiselerSol Roy RosenthalKate NelsonVijai K. Moses
- Topics
- Bladder and Urothelial Cancer Treatments (5 papers)Immune responses and vaccinations (5 papers)Urinary and Genital Oncology Studies (3 papers)
- Cited by
- UrologySurgeryInfectious Diseases
- Partner nations
- United States
In The Last Decade
Ray G. Crispen
16 papers receiving 462 citations
Peers
Comparison fields: 5 of 73
- Surgery 289
- Epidemiology 127
- Infectious Diseases 120
- Immunology 109
- Urology 80
Countries citing papers authored by Ray G. Crispen
This map shows the geographic impact of Ray G. Crispen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ray G. Crispen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ray G. Crispen more than expected).
Fields of papers citing papers by Ray G. Crispen
This network shows the impact of papers produced by Ray G. Crispen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ray G. Crispen. The network helps show where Ray G. Crispen may publish in the future.
Co-authorship network of co-authors of Ray G. Crispen
This figure shows the co-authorship network connecting the top 25 collaborators of Ray G. Crispen. A scholar is included among the top collaborators of Ray G. Crispen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ray G. Crispen. Ray G. Crispen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Tuberculosis in Physicians | 1 |
| 2 | 12 | |
| 3 | 6 | |
| 4 | 21 | |
| 5 | 296 | |
| 6 | 68 | |
| 7 | BCG and cancer. | 1 |
| 8 | Differences in biological activity among batches of lyophilized tice Bacillus Calmette-Guérin and their association with clinical course in Stage I lung cancer. | 13 |
| 9 | Humoral and cellular immunity studies in patients with Vogt-Koyanagi-Harada syndrome and pars planitis. | 26 |
| 10 | 9 | |
| 11 | Prostate carcinoma: immunostaging and adjuvant immunotherapy with BCG. | 1 |
| 12 | Adjuvant chemotherapy and immunotherapy in high risk patients with melanoma. | 1 |
| 13 | BCG vaccine. Past, present, future. | 1 |
| 14 | 10 | |
| 15 | 8 | |
| 16 | Rapid testing of freeze dried bcg vaccine for stability and viability | 12 |
About Ray G. Crispen
Ray G. Crispen is a scholar working on Immunology, Biotechnology and Ophthalmology, having authored 16 papers that have together received 486 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Immune responses and vaccinations (5 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Urology (80 citations), Surgery (289 citations) and Infectious Diseases (120 citations). Ray G. Crispen has collaborated with scholars based in United States. Frequent co-authors include Donald L. Lamm, Timothy J. Holzer, Kenrad E. Nelson, B. R. Andersen, P. Jan Geiseler, Sol Roy Rosenthal, Kate Nelson, Vijai K. Moses, James A. Bennett and Daniel Zelterman. Their work appears in journals such as The Journal of Urology, Infection and Immunity and Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.